About the AURA Surveillance System

AURA collates data from a wide range of sources to provide a comprehensive and integrated picture of patterns and trends in antimicrobial resistance and antimicrobial use in human health across Australia. 

The Commission established the AURA Surveillance System to inform and support implementation of strategies to prevent and contain antimicrobial resistance.

Four long-term surveillance programs provided the foundation for the establishment of AURA Surveillance System:

In addition, data and reports have been included in national reporting from:

  • The National Alert System for Critical Antimicrobial Resistances (CARAlert), which was established by the Commission in 2016 to provide information on priority organisms that are resistant to last-line antimicrobials
  • The National Neisseria Network, on Neisseria gonorrhoeae and N. meningitidis
  • The National Notifiable Diseases Surveillance System, on Mycobacterium tuberculosis
  • The Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS)
  • The NPS MedicineWise MedicineInsight program
  • Sullivan Nicolaides Pathology, on rates of antimicrobial resistance from the community and private hospital settings
  • HOTspots on rates of antimicrobial resistance from across northern Australia
  • The C. difficile Antimicrobial Resistance Surveillance (CDARS) study.